Rafick Sékaly, the Canada Research Chair in Human Immunology, has been a pioneer in several fields of human immunology and HIV/AIDS pathogenesis and treatments. Using several novel technologies developed in his lab, he was able to demonstrate in collaboration with other researchers the protective and deleterious features of the primary cellular immune responses in HIV infected patients which have led to several investigator driven national and international clinical trials. He has received several honours and awards including the Forgaty Fellowship of the National Institutes of Health of Maryland, Chercheur boursier « Senior 1 » of the Fonds de la recherché en sauté du Québec, Prix du jeune chercheur of the Club de recherches cliniques du Quebec and Senior Scientist Salary Support Awards from the Medical Research Council of Canada. As Founder and Scientific Director of the CANVAC Network of Centre of Excellence, Dr Sékaly hopes to improve the quality of life of Canadians by using novel technologies and a multidisciplinary approach in order to develop vaccines for the prevention and treatment of chronic diseases like AIDS, hepatitis C and cancer.